Gland Pharma Other Announcement
Gland Pharma Limited has filed the confirmation certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended September 30, 2026.
ALFA Filings
Every announcement, straight from the exchange
Every Gland Pharma other announcement announcement on NSE and BSE, newest first, each with its own page.
Time
4 announcements
Gland Pharma Limited has filed the confirmation certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended September 30, 2026.
Gland Pharma Limited submitted its Business Responsibility and Sustainability Report (BRSR) for the financial year ended March 31, 2026, as per SEBI regulations.
Gland Pharma submitted its quarterly shareholding pattern for the period ending June 30, 2026. This is a routine regulatory disclosure.
Gland Pharma filed its Annual Secretarial Compliance Report for the financial year ended March 31, 2026. The report confirms full compliance with SEBI regulations and listing requirements.